(Q74787680)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9669203%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

review article

1 reference

title

The immunopharmacology of head and neck cancer: an update (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9669203%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

1 reference

1 reference

head and neck carcinoma

1 reference

J W Hadden

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9669203%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 November 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9669203%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Immunopharmacology

13 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9669203%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9669203%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

11-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9669203%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

629-644

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9669203%20AND%20SRC:MED&resulttype=core&format=json

Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patients

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Mononuclear phagocyte function in head and neck cancer: NBT-dye reduction, maturation and migration of peripheral blood monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Mononuclear phagocyte function in head and neck cancer: depression of murine macrophage accumulation by low molecular weight factors derived from head and neck carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Mononuclear phagocyte function in head and neck cancer. Chemotactic responsiveness of blood monocytes in correlation between histologic grade of the tumor and infiltration of these cells into the tumor area

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Deficient cell-mediated immunity in head and neck cancer patients secondary to autologous suppressive immune cells

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

The doubtful relevance of nonspecific immune reactivity in patients with squamous cell carcinoma of the head and neck region

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

The effect of indomethacin on the growth of epidermoid carcinoma of the palate in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Gene therapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Nutritional status and general immune competence in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Gene therapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Gene therapy for head and neck cancer. Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21).

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Treatment of nasopharyngeal carcinoma with human leukocyte interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Monoclonal antibodies against epithelial antigens in laryngeal carcinomas (an immunocytochemical and clinico-pathological investigation)

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

The effect of preoperative local interleukin-2 (IL-2) injections in patients with head and neck squamous cell carcinoma. An immunological study

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Interleukin-2 injected around tumor-draining lymph nodes in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Immunomodulation therapy for squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Administration of a prostaglandin synthetase inhibitor associated with an increased immune cell infiltrate in squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Relationship of 4F2 antigen with local growth and metastatic potential of squamous cell carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Development of monoclonal antibodies with specificity to oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Multidisciplinary treatment of head and neck cancer using BCG, OK-432, and GE-132 as biologic response modifiers

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Interleukin-6 and acute-phase proteins in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Effects of radiation therapy on T-lymphocyte subpopulations in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Defective monocyte chemotaxis in patients with epidermoid tumors of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Strategies of immune reconstitution: effects of lymphokines on murine T cell development in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

1 reference

7 January 2021

The treatment of zinc deficiency is an immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Immunotherapy with natural interleukins and/or thymosin alpha 1 potently augments T-lymphocyte responses of hydrocortisone-treated aged mice

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Interleukins and contrasuppression induce immune regression of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Interferons and other cytokines in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Serum tumor markers of head and neck cancer: current status.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Monoclonal antibody G6K12 specific for membrane-associated differentiation marker of human stratified squamous epithelia and squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice?

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Immunostimulation of patients with head and neck cancer. In vitro and preliminary clinical experiences.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Phytohaemagglutinin (PHA) skin test in predicting prognosis in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Radiotherapy and head and neck cancer. Role of lymphocyte respontse and clinical stage

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Immunobiologic Staging of Patients with Carcinoma of the Head and Neck

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Update on immunology of head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

In vivo effects of thymostimulin treatment on monocyte polarization, dendritic cell clustering and serum p15E-like trans-membrane factors in operable head and neck squamous cell carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Thymostimulin enhancement of T-cell infiltration into head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

The effects of thymostimulin on immunological function in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Head and Neck Squamous Cell Carcinoma Cell Line-Induced Suppression of in vitro Lymphocyte Proliferative Responses

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Phytohemagglutinin (PHA) skin test in the diagnosis of cellular immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Indomethacin sensitive suppressor cell activity in head and neck cancer patients pre- and postirradiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Clinical and immunopathological results of a phase II study of perilymphatically injected recombinant interleukin-2 in locally far advanced, nonpretreated head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Prognostic significance of prostaglandin E2 production by mononuclear cells and tumor cells in squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Changes in the Ki-67 labeling rates of head and neck squamous cell carcinomas during preoperative radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Regression of Head and Neck Carcinoma With a Prostaglandin-Synthesis Inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Prognostic significance of sinus histiocytosis in metastatic laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Phase I-II study of advanced head and neck squamous cell carcinoma patients treated with recombinant human interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Zinc induces thymulin secretion from human thymic epithelial cells in vitro and augments splenocyte and thymocyte responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Local Administration Trials of Interleukin-2 for Head and Neck Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Tumor regression and temporary restoration of immune response after plasmapheresis in a patient with recurrent oral cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Prognostic significance of prostaglandin E2 production in fresh tissues of head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Serum levels of tumor necrosis factor in squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Local adoptive immunotherapy of advanced head and neck tumors with LAK cells and interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Defective monocyte chemotaxis in patients with head and neck cancer. Restoration after treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Prolonged depression of cellular immunity in cured laryngopharyngeal cancer patients treated with radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Intensive recombinant interleukin-2 and alpha-interferon therapy in patients with advanced head and neck squamous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

A natural cytokine mixture (IRX-2) and interference with immune suppression induce immune mobilization and regression of head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Isolation and purification of a squamous cell carcinoma of the head and neck-associated antigen identified by autologous antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Phase Ib trial of the effect of peritumoral and intranodal injections of interleukin-2 in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Contribution of serum inhibitory factors and immune cellular defects to the depressed cell-mediated immunity in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Definite vs adjuvant radiotherapy. Comparative effects on lymphocyte subpopulations in patients with head and neck squamous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

Phytohemagglutinin skin tests in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900063-5

7 January 2021

10.1016/S0192-0561(97)00063-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9669203%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference